Insomnia severity is an indicator of suicidal ideation during a depression clinical trial

Sleep Medicine

Volumn 11, Issue 9, 2010, Pages 822-827

  McCall, W Vaughn ^a   Blocker, Jill N ^a   D'Agostino, Ralph ^a   Kimball, James ^a   Boggs, Niki ^a   Lasater, Barbara ^a   Rosenquist, Peter B ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Clinical trial; Depression; Eszopiclone; Insomnia; Placebo; Suicide

Indexed keywords

ESZOPICLONE; FLUOXETINE; PLACEBO;

ADD ON THERAPY; ADULT; ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INSOMNIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SCORING SYSTEM; SUICIDAL IDEATION; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AZABICYCLO COMPOUNDS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUICIDAL IDEATION; YOUNG ADULT;

EID: 84755161818     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.04.004     Document Type: Article

References (63)

1. Mann J.J., Apter A., Bertolote J., et al. Suicide prevention strategies: a systematic review. JAMA 2005, 294:2064-2074.
2. Maris R. Suicide. Lancet 2002, 360:319-326.
3. Coryell W., Young E.A. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry 2005, 66:412-417.
4. Brown G.K., Beck A.T., Steer R.A., et al. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol 2000, 68:371-377.
5. Hall R., Platt D., Hall R. Suicide risk assessment: a review of risk factors for suicide in 100 patients who made severe suicide attempts. Psychosomatics 1999, 40:18-27.
6. Oquendo M., Malone K., Mann J.J. Suicide: risk factors and prevention in refractory major depression. Depress Anxiety 1997, 5:202-211.
7. Oquendo M., Mann J.J. Intervention research for suicidal behavior. Lancet 2003, 362:844-845.
8. Tishler C.L., McKenry P.C., Morgan K. Adolescent suicide attempts: some significant factors. Suicide Life Threat Behav 1981, 11:86-92.
9. Bailly D., Bailly-Lambin I., Querleu D., et al. Le sommeil des adolescents et ses troubles Une enquete en mileiu scolaire. L'Encephale 2004, 30:352-359.
10. Choquet M., Menke H. Suicidal thoughts during early adolescence. prevalence, associated troubles and help-seeking behavior. Acta Psychiatr Scand 1989, 81:170-177.
11. Choquet M., Kovess V. Suicidal thoughts among adolescents: an intercultural approach. Adolescence 1993, 28:649-661.
12. Liu X. Sleep and adolescent suicidal behavior. Sleep 2004, 27:1351-1358.
13. Vignau J., Bailly D., Duhamel A., et al. Epidemiologic study of sleep quality and troubles in French secondary school adolescents. J Adolesc Health 1997, 21:343-350.
14. Roberts R., Roberts C., Chen I. Functioning of adolescents with symptoms of disturbed sleep. J Youth Adolesc 2001, 30:1-18.
15. Cukrowicz K., Otamendi A., Pinto J.V., et al. The impact of insomnia and sleep disturbances on depression and suicidality. Dreaming 2006, 16:1-10.
16. Barbe R.P., Williamson D., Bridge J.A., et al. Clinical differences between suicidal and nonsuicidal depressed children and adolescents. J Clin Psychiatry 2005, 66:492-498.
17. Goldstein T.R., Bridge J.A. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol 2008, 76:84-91.
18. Fawcett J., Scheftner W.A., Fogg L., et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990, 147:1189-1194.
19. Tanskanen A., Tuomilehto J., Vinamaki H., et al. Nightmares as predictors of suicide. Sleep 2001, 24:844-847.
20. Fujino Y., Mizoue T., Tokui N., et al. Prospective cohort study of stress, life satisfaction, self-rated health, insomnia, and suicide death in Japan. Suicide Life Threat Behav 2005, 35:227-237.
21. Turvey C.L., Conwell Y., Jones M.P., et al. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry 2002, 10:398-406.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
23. Edinger J.D., Bonnet M.H., Bootzin R.R., et al. Derivation of research diagnostic criteria for insomnia: Report of an American Academy of Sleep Medicine work group. Sleep 2004, 27:1567-1596.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: 1994.
25. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
26. McCall W.V., Kimball J., Boggs N., et al. Prevalence and prediction of primary sleep disorders in a clinical trial of depressed patients with insomnia. J Clin Sleep Med 2009, 5:454-458.
27. Beck A.T., Kovacs M., Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979, 47:343-352.
28. Beck A.T., Brown G.K., Steer R.A. Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther 1997, 35:1039-1046.
29. Beck A.T., Brown G.K., Steer R.A., et al. Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients. Suicide Life Threat Behav 1999, 29:1-9.
30. Bastien C.H., Vallieres A., Morin C.M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001, 2:297-307.
31. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 1988, 8:77-100.
32. Kellner C., Fink M., Knapp R., et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry 2005, 162:977-982.
33. Cipriani A., Pretty H., Hawton K., et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005, 162:1805-1819.
34. Coffey C.E., McCall V., Hoelscher T.J. Effects of ECT on polysomnographic sleep: a pilot prospective study. Convuls Ther 1988, 4:269-279.
35. Billiard M. Lithium carbonate: effects on sleep patterns of normal and depressed subjects and its use in sleep-wake pathology. Pharmacopsychiatry 1987, 20:195-196.
36. Barraclough B., Pallis D.J. Depression followed by suicide: a comparison of depressed suicides with living depressives. Psychol Med 1975, 5:61.
37. Agargun M., Kara H., Solmaz M. Subjective sleep quality and suicidality in patients with major depression. J Psychiat Res 1997, 31:377-381.
38. Agargun M.Y., Kara H., Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 1997, 58:249-251.
39. Agargun M., Cilli A., Kara H., et al. Repetitive and frightening dreams and suicidal behavior in patients with major depression. Compr Psychiatry 1998, 39:198-202.
40. Smith M., Perlis M., Haythornthwaite J. Suicidal ideation in outpatients with chronic musculoskeletal pain. Clin J Pain 2004, 20:111-118.
41. Bernert R., Joiner T., Cukrowicz K., et al. Suicidality and sleep disturbances. Sleep 2005, 28:1135-1141.
42. Chellappa S., Araujo J. Sleep disorders and suicidal ideation in patients with depressive disorder. Psychiatry Res 2007, 153:131-136.
43. Bernert R., Reeve J., Perlis M., et al. Insomnia and nightmares as predictors of elevated suicide risk among patients seeking admission to emergency mental health facility. Sleep 2009, 32:A365-A366.
44. Agargun M., Besiroglu L., Cilli A., et al. Nightmares, suicide attempts, and melancholic features in patients with unipolar major depression. J Affect Disord 2007, 98:267-270.
45. Sjostrom N., Waern M., Hetta J. Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep 2007, 30:91-95.
46. Goodwin R.D., Marusic A. Association between short sleep and suicidal ideation and suicide attempt among adults in the general population. Sleep 2008, 31:1097-1101.
47. Singareddy R., Balon R. Sleep and suicide in psychiatric patients. Ann Clin Psychiatry 2001, 13:93-101.
48. Liu X., Buysse D. Sleep and youth suicidal behavior: a neglected field. Curr Opin Psychiatry 2006, 19:288-293.
49. Agargun M.Y., Cartwright R. REM sleep, dream variables and suicidality in depressed patients. Psychiatry Res 2003, 119:33-39.
50. Keshavan M.S., Reynolds C.F., Montrose D., et al. Sleep and suicidality in psychotic patients. Acta Psychiatr Scand 1994, 89:122-125.
51. Espie C., Inglis S., Harvey L., et al. Insomniacs' attributions: psychometric properties of the dysfunctional beliefs and attitudes about sleep scale and the sleep disturbance questionnaire. J Psychosom Res 2000, 48:141-148.
52. Carney C., Edinger J., Manber R., et al. Beliefs about sleep in disorders characterized by sleep and mood disturbance. J Psychosom Res 2007, 62:179-188.
53. DiMascio A., Weissman M.M., Prusoff B.A., et al. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 1979, 36:1450-1456.
54. Nierenberg A.A., Keefe B.R., Leslie V.C., et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999, 60:221-225.
55. Beasley C., Nilsson M., Koke S., et al. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose. J Clin Psychiatry 2000, 61:722-728.
56. Cook M., Conner J. Retrospective review of hypnotic use in combination with fluoxetine and sertraline. Clin Drug Invest 1995, 9:212-216.
57. Smith W.T., Londborg P.D., Glaudin V., et al. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?. J Affect Disord 2002, 70:251-259.
58. Londborg P.D., Smith W.T., Glaudin V., et al. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 2000, 61:73-79.
59. Asnis G.M., Chakraburtty A., DuBoff E.A., et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 1999, 60:668-676.
60. Fava M., McCall V., Krystal A., et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006, 59:1052-1060.
61. Krystal A., Walsh J., Fava M., et al. Analysis of individual items of the hamilton depression scale in a study of eszopiclone/fluoxetine co-therapy. Sleep 2006, 29:A240.
62. Perlis R., Purcell S., Fava M., et al. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 2007, 64:689-697.
63. Kripke D.F., Garfinkel L., Wingard D.L., et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002, 59:131-136.